BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30737829)

  • 1. Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.
    Driot D; Jouanjus E; Oustric S; Dupouy J; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2019 Jun; 85(6):1260-1269. PubMed ID: 30737829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
    Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE
    Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
    Vickers-Smith R; Sun J; Charnigo RJ; Lofwall MR; Walsh SL; Havens JR
    Drug Alcohol Depend; 2020 Jan; 206():107709. PubMed ID: 31732295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Evidence on Abuse and Misuse of Gabapentinoids.
    Hägg S; Jönsson AK; Ahlner J
    Drug Saf; 2020 Dec; 43(12):1235-1254. PubMed ID: 32857333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin and pregabalin: do the benefits outweigh the harms?
    Morrison EE; Sandilands EA; Webb DJ
    J R Coll Physicians Edinb; 2017 Dec; 47(4):310-313. PubMed ID: 29537399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
    Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
    Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
    Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
    Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings.
    Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA
    Addiction; 2019 Jun; 114(6):1026-1034. PubMed ID: 30098227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Pregabalin and Worsening Heart Failure: A Nationwide Cohort Study.
    Lund M; Poulsen G; Pasternak B; Worm Andersson N; Melbye M; Svanström H
    Drug Saf; 2020 Oct; 43(10):1035-1044. PubMed ID: 32651945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misuse and abuse of pregabalin and gabapentin: cause for concern?
    Schifano F
    CNS Drugs; 2014 Jun; 28(6):491-6. PubMed ID: 24760436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?
    Peckham AM; Fairman KA; Sclar DA
    Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016.
    Pauly NJ; Delcher C; Slavova S; Lindahl E; Talbert J; Freeman PR
    J Manag Care Spec Pharm; 2020 Mar; 26(3):246-252. PubMed ID: 32105169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse and Misuse of Pregabalin and Gabapentin.
    Evoy KE; Morrison MD; Saklad SR
    Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the risk of dependence on gabapentinoids].
    Bonnet U; Scherbaum N
    Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin misuse: preventing potential problems in New Zealand.
    Ponton R
    N Z Med J; 2018 Jul; 131(1478):50-54. PubMed ID: 30001306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database.
    Ortiz de Landaluce L; Carbonell P; Asensio C; Escoda N; López P; Laporte JR
    Drug Saf; 2018 Dec; 41(12):1325-1331. PubMed ID: 29956217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
    Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
    Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug abuse of pregabalin - state of the situation, risks and means of control].
    Laribi M; Chaouali N; Jaballah S; Amira D; Hedhili A
    Ann Pharm Fr; 2023 May; 81(3):419-424. PubMed ID: 36375531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.